Sep 10, 2026 08:05AM
Sep 10, 2026 08:05AM
Sep 1, 2026 04:05PM
Aug 26, 2026 08:05AM
Aug 13, 2026 08:05AM
Aug 3, 2026 04:05PM
Aug 3, 2026 08:05AM Candel Therapeutics to present prostate cancer data at ASTRO 2026
Aug 3, 2026 08:05AM
Jul 29, 2026 08:05AM
Jul 8, 2026 04:05PM
Jul 1, 2026 04:05PM
Jun 30, 2026 08:05AM
Jun 30, 2026 08:05AM
Jun 25, 2026 08:05AM Candel Therapeutics names Mark Sims as chief commercial officer
Jun 25, 2026 08:05AM
Jun 2, 2026 08:05AM
Jun 2, 2026 08:05AM
Jun 1, 2026 04:05PM
May 15, 2026 04:05PM
May 15, 2026 04:05PM
May 14, 2026 08:05AM Candel Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
May 13, 2026 08:05AM
May 4, 2026 08:05AM
May 4, 2026 08:05AM
May 1, 2026 04:05PM
Apr 29, 2026 08:05AM
Apr 29, 2026 08:05AM
Apr 2, 2026 04:05PM Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 17, 2026 08:05AM
Mar 17, 2026 08:05AM
Mar 13, 2026 06:10AM
Mar 12, 2026 08:05AM
Mar 9, 2026 08:05AM
Mar 9, 2026 08:05AM
Mar 2, 2026 04:05PM Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb 24, 2026 08:05AM
Feb 19, 2026 09:40PM
Feb 19, 2026 09:40PM
Feb 19, 2026 04:05PM
Feb 19, 2026 04:05PM
Feb 19, 2026 04:02PM
Feb 19, 2026 04:01PM Candel Therapeutics Announces $100M Royalty Funding Agreement with RTW to Support the Potential Launch of Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer
Feb 11, 2026 08:05AM
Feb 2, 2026 04:05PM
Nov 17, 2025 04:05PM
Nov 17, 2025 04:05PM
Nov 13, 2025 08:25AM
Nov 4, 2025 09:00AM
Nov 4, 2025 09:00AM Candel Therapeutics Showcases Immunotherapy Leadership at SITC 2025, Demonstrating Integration of Clinical Innovation, Multi-Omics, and Artificial Intelligence to Advance Next-Generation Immunotherapi
Nov 3, 2025 08:05AM

330,751 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All